- Home
- PYPD vs SWAG Comparison
PYPD vs SWAG Comparison
Compare PYPD & SWAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- SWAG
- Stock Information
- Founded
- PYPD 2008
- SWAG 1994
- Country
- PYPD Israel
- SWAG United States
- Employees
- PYPD N/A
- SWAG N/A
- Industry
- PYPD Medical/Dental Instruments
- SWAG Advertising
- Sector
- PYPD Health Care
- SWAG Consumer Discretionary
- Exchange
- PYPD Nasdaq
- SWAG Nasdaq
- Market Cap
- PYPD 34.8M
- SWAG 30.4M
- IPO Year
- PYPD 2020
- SWAG 2021
- Fundamental
- Price
- PYPD $3.49
- SWAG $1.88
- Analyst Decision
- PYPD Strong Buy
- SWAG
- Analyst Count
- PYPD 5
- SWAG 0
- Target Price
- PYPD $12.00
- SWAG N/A
- AVG Volume (30 Days)
- PYPD 52.0K
- SWAG 128.0K
- Earning Date
- PYPD 11-12-2025
- SWAG 11-06-2025
- Dividend Yield
- PYPD N/A
- SWAG N/A
- EPS Growth
- PYPD N/A
- SWAG N/A
- EPS
- PYPD N/A
- SWAG N/A
- Revenue
- PYPD N/A
- SWAG $108,405,000.00
- Revenue This Year
- PYPD N/A
- SWAG N/A
- Revenue Next Year
- PYPD N/A
- SWAG N/A
- P/E Ratio
- PYPD N/A
- SWAG N/A
- Revenue Growth
- PYPD N/A
- SWAG 38.74
- 52 Week Low
- PYPD $2.30
- SWAG $0.73
- 52 Week High
- PYPD $3.93
- SWAG $1.96
- Technical
- Relative Strength Index (RSI)
- PYPD 54.23
- SWAG 60.89
- Support Level
- PYPD $3.35
- SWAG $1.79
- Resistance Level
- PYPD $3.54
- SWAG $1.96
- Average True Range (ATR)
- PYPD 0.12
- SWAG 0.09
- MACD
- PYPD 0.00
- SWAG -0.00
- Stochastic Oscillator
- PYPD 75.49
- SWAG 73.44
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About SWAG Stran & Company Inc.
Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.